Efavirenz plasma concentrations and efficiency

AIDS. 2001 Jun 15;15(9):1192-4. doi: 10.1097/00002030-200106150-00022.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • AIDS-Related Opportunistic Infections / blood
  • AIDS-Related Opportunistic Infections / drug therapy*
  • AIDS-Related Opportunistic Infections / virology
  • Alkynes
  • Anti-HIV Agents / blood
  • Anti-HIV Agents / pharmacokinetics*
  • Anti-HIV Agents / therapeutic use
  • Benzoxazines
  • Cyclopropanes
  • Dose-Response Relationship, Drug
  • Humans
  • Oxazines / blood
  • Oxazines / pharmacokinetics*
  • Oxazines / therapeutic use
  • Reverse Transcriptase Inhibitors / blood
  • Reverse Transcriptase Inhibitors / pharmacokinetics*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Treatment Outcome
  • Tuberculosis / blood
  • Tuberculosis / drug therapy*
  • Tuberculosis / virology
  • Viral Load

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Oxazines
  • Reverse Transcriptase Inhibitors
  • efavirenz